The Business Times

Companies & Markets

The Business Times
Subscribe
Share on FacebookShare on TwitterView more
The Business Times
Create a free account with Business Times for seamless access across SPH Media products.
REGISTER
LOGIN

Companies & Markets

SUBSCRIBERS

Secretive biotech unicorn Moderna unveils research pipeline, financials

Published Tue, Jan 10, 2017 · 09:50 PM
Share this article.

San Francisco

MODERNA Therapeutics Inc, one of the best-funded private biotechnology companies in the US, unveiled its long-secret research and development pipeline on Monday, including experimental vaccines, cancer treatments and a cardiovascular therapy.

The Cambridge, Massachusetts-based startup has about US$1.3 billion in cash on hand from investors, pharmaceutical partners and government grants, according to a presentation on Monday at the JPMorgan Chase & Co Healthcare Conference in San Francisco. It's privately valued at about US$5 billion, according to a person familiar with the matter who asked not to be identified because the matter wasn't public.

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to  t.me/BizTimes

Companies & Markets

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

Get the latest coverage and full access to all BT premium content.

SUBSCRIBE NOW

Browse corporate subscription here